Israel’s Taro Sues India’s Sun Over Sale Plans For Irish Unit
This article was originally published in PharmAsia News
Executive Summary
The canceled sale of India's Sun Pharma to Israel's Taro Pharma has led to a lawsuit filed in Israel over Sun efforts to stop the associated sale of Taro holdings in Ireland. Last month, Taro withdrew plans to acquire Sun for $460 million. The planned merger had involved Taro selling its Irish operations, but required Sun's consent, which Taro says Sun now refuses to give. Taro also has pending another suit against Sun involving alleged Sun efforts to increase its voting power in Taro. (Click here for more